Greater Combined Reductions in HBA1C ≥1.0% and Weight ≥5.0% With Semaglutide vs. Comparators in Type-2 Diabetes

Helena W. Rodbard, Srikanth Bellary, Irene Hramiak, Yutaka Seino, Robert Silver, Lars Holm Damgaard, Gurudutt Nayak, Jeppe Zacho, and Vanita R. Aroda

Endocrine Practice

In-Press

ABSTRACT PDF